Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD ...
CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development conferenceParsortix platform shown to be compatible with the Roche BenchMark ...
MALMÖ, SE / ACCESS Newswire / November 5, 2025 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE) today published its Interim Report Q3 for 2025 (January - September), which is now ...
Addison enables continuous patient oversight, early intervention, and intelligent adherence through customizable RPM/CCM ...
With more than 700,000 square feet of advanced operations within the next 12 months, Strive solidifies its position as a ...
The US Therapeutic Plasma Exchange Market represents a critical segment within the broader apheresis and blood purification ...
Press Release  Medical technology leader, Medtronic has successfully concluded the UK leg of its European ACM2U Truck ...
Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" ...
Expert consensus predicts integration of CTC testing into routine clinical practice within 5 years  2.    CTCs provide distinct and impactful information that is not captured by circulating tumour DNA ...
Raiding Cartels While Blocking CuresThe time has come for Cole's DEA to separate crime from science, ending the seven year blockade on medical cannabis and proving that true public safety includes ...
KYGEVVI® (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom ...
Faith Recovery, a Williamsburg-based drug recovery program, recently earned a three-year accreditation from the Commission on ...